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Background

Brain natriuretic peptide (BNP) is used as a marker of myocardial
dysfunction in multiple clinical settings. We have anecdotally observed
that during ECMO weaning, BNP levels remain stable or decreased in
patients who survive after decannulation, but are elevated or rise in
other children who die following decannulation.

Hypothesis
We hypothesized that trends in BNP levels during weaning from V-A
ECMO may be useful to predict survival after decannulation from ECMO.

Methods
Design: Retrospective cohort study
Participants: Patients requiring V-A ECMO for cardiac failure
admitted to Children’s Mercy Hospital PICU from May 2011-Feb 2014
who had BNP levels while on ECMO were included

Measurements: The BNP level on full ECMO support and the BNP
level on the lowest level of ECMO support prior to
decannulation were recorded. Mann-Whitney U was used to
compare BNP levels between those who died within 48 hours of
decannulation, those who survived >48 hours off ECMO, and those who
survived to hospital discharge.

Results
Twelve patients met inclusion criteria. Eleven had congenital heart
disease, 7 had single ventricle physiology. Median age was 57.5
days (range 10-2237). Median weight was 3.85kg (range 2.7-28).
Four patients survived >48hrs after decannulation (33.3%) and 2
patients survived to hospital discharge (16.7%). Among non
survivors, median time to death after decannulation was 2.13
hours (range 0.13-1601).
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Despite apparent clinical and echocardiographic evidence of adequate
myocardial function and successful weaning towards decannulation, up
to 33% of children who separate from cardiac ECMO do not survive to
hospital discharge.

5000

3000
2000

Survivors had a decrease or no change in their BNP level with
weaning of ECMO support. Of non survivors, 57% had an
increase BNP level or a BNP level that remained >5,000 pg/mL
with ECMO weaning.
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At the time of minimal ECMO support, there was a trend towards
lower median BNP levels in those who survived greater than 48
hours (314, 153-655) vs. those who died within 48 hours of
decannulation (2671, 199-5001), p=0.088. There was a stronger
trend towards lower BNP levels at the time of minimal ECMO
support in those who survived to hospital discharge (190,
153-227) compared to all those who died (1174, 199-5001),
p=0.059.
STUDY LIMITATIONS: Our study was limited by the retrospective
study design, small sample size, and the inability to quantify BNP
levels >5,000 pg/mL.

Conclusion
BNP may be a useful biomarker to assess myocardial function
while weaning ECMO support and warrants further study.

